These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 12925791)
21. Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidines. Gangjee A; Adair O; Queener SF J Med Chem; 1999 Jul; 42(13):2447-55. PubMed ID: 10395486 [TBL] [Abstract][Full Text] [Related]
22. New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity. Rosowsky A; Forsch RA; Sibley CH; Inderlied CB; Queener SF J Med Chem; 2004 Mar; 47(6):1475-86. PubMed ID: 14998335 [TBL] [Abstract][Full Text] [Related]
23. Ligand-induced conformational changes in the crystal structures of Pneumocystis carinii dihydrofolate reductase complexes with folate and NADP+. Cody V; Galitsky N; Rak D; Luft JR; Pangborn W; Queener SF Biochemistry; 1999 Apr; 38(14):4303-12. PubMed ID: 10194348 [TBL] [Abstract][Full Text] [Related]
24. Kinetic and structural analysis for potent antifolate inhibition of Pneumocystis jirovecii, Pneumocystis carinii, and human dihydrofolate reductases and their active-site variants. Cody V; Pace J; Queener SF; Adair OO; Gangjee A Antimicrob Agents Chemother; 2013 Jun; 57(6):2669-77. PubMed ID: 23545530 [TBL] [Abstract][Full Text] [Related]
25. Comparison of ternary complexes of Pneumocystis carinii and wild-type human dihydrofolate reductase with coenzyme NADPH and a novel classical antitumor furo[2,3-d]pyrimidine antifolate. Cody V; Galitsky N; Luft JR; Pangborn W; Gangjee A; Devraj R; Queener SF; Blakley RL Acta Crystallogr D Biol Crystallogr; 1997 Nov; 53(Pt 6):638-49. PubMed ID: 15299851 [TBL] [Abstract][Full Text] [Related]
26. New insights into DHFR interactions: analysis of Pneumocystis carinii and mouse DHFR complexes with NADPH and two highly potent 5-(omega-carboxy(alkyloxy) trimethoprim derivatives reveals conformational correlations with activity and novel parallel ring stacking interactions. Cody V; Pace J; Chisum K; Rosowsky A Proteins; 2006 Dec; 65(4):959-69. PubMed ID: 17019704 [TBL] [Abstract][Full Text] [Related]
27. Structural analysis of a holoenzyme complex of mouse dihydrofolate reductase with NADPH and a ternary complex with the potent and selective inhibitor 2,4-diamino-6-(2'-hydroxydibenz[b,f]azepin-5-yl)methylpteridine. Cody V; Pace J; Rosowsky A Acta Crystallogr D Biol Crystallogr; 2008 Sep; 64(Pt 9):977-84. PubMed ID: 18703847 [TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with omega-carboxyalkoxy or omega-carboxy-1-alkynyl substitution in the side chain. Chan DC; Fu H; Forsch RA; Queener SF; Rosowsky A J Med Chem; 2005 Jun; 48(13):4420-31. PubMed ID: 15974594 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents. Gangjee A; Adair OO; Queener SF J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957 [TBL] [Abstract][Full Text] [Related]
30. Selective Pneumocystis carinii dihydrofolate reductase inhibitors: design, synthesis, and biological evaluation of new 2,4-diamino-5-substituted-furo[2,3-d]pyrimidines. Gangjee A; Guo X; Queener SF; Cody V; Galitsky N; Luft JR; Pangborn W J Med Chem; 1998 Apr; 41(8):1263-71. PubMed ID: 9548816 [TBL] [Abstract][Full Text] [Related]
31. Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents. Gangjee A; Vidwans AP; Vasudevan A; Queener SF; Kisliuk RL; Cody V; Li R; Galitsky N; Luft JR; Pangborn W J Med Chem; 1998 Aug; 41(18):3426-34. PubMed ID: 9719595 [TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and biological evaluation of 2,4-diamino-5-methyl-6-substituted-pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors. Gangjee A; Lin X; Queener SF J Med Chem; 2004 Jul; 47(14):3689-92. PubMed ID: 15214795 [TBL] [Abstract][Full Text] [Related]
33. Targeting species specific amino acid residues: Design, synthesis and biological evaluation of 6-substituted pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors and potential anti-opportunistic infection agents. Shah K; Lin X; Queener SF; Cody V; Pace J; Gangjee A Bioorg Med Chem; 2018 May; 26(9):2640-2650. PubMed ID: 29691153 [TBL] [Abstract][Full Text] [Related]
34. Preferential selection of isomer binding from chiral mixtures: alternate binding modes observed for the E and Z isomers of a series of 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines as ternary complexes with NADPH and human dihydrofolate reductase. Cody V; Piraino J; Pace J; Li W; Gangjee A Acta Crystallogr D Biol Crystallogr; 2010 Dec; 66(Pt 12):1271-7. PubMed ID: 21123866 [TBL] [Abstract][Full Text] [Related]
35. Conformationally restricted analogues of trimethoprim: 2,6-diamino-8-substituted purines as potential dihydrofolate reductase inhibitors from Pneumocystis carinii and Toxoplasma gondii. Gangjee A; Vasudevan A; Queener SF J Med Chem; 1997 Sep; 40(19):3032-9. PubMed ID: 9301665 [TBL] [Abstract][Full Text] [Related]
36. Correlations of inhibitor kinetics for Pneumocystis jirovecii and human dihydrofolate reductase with structural data for human active site mutant enzyme complexes. Cody V; Pace J; Makin J; Piraino J; Queener SF; Rosowsky A Biochemistry; 2009 Mar; 48(8):1702-11. PubMed ID: 19196009 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of nonclassical 2,4-diamino-5-methylpyrido[2,3-d]pyrimidines with novel side chain substituents as potential inhibitors of dihydrofolate reductases. Gangjee A; Vasudevan A; Queener SF J Med Chem; 1997 Feb; 40(4):479-85. PubMed ID: 9046338 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and dihydrofolate reductase inhibitory activities of 2,4-diamino-5-deaza and 2,4-diamino-5,10-dideaza lipophilic antifolates. Gangjee A; Devraj R; Queener SF J Med Chem; 1997 Feb; 40(4):470-8. PubMed ID: 9046337 [TBL] [Abstract][Full Text] [Related]
39. Crystal structures of Escherichia coli dihydrofolate reductase complexed with 5-formyltetrahydrofolate (folinic acid) in two space groups: evidence for enolization of pteridine O4. Lee H; Reyes VM; Kraut J Biochemistry; 1996 Jun; 35(22):7012-20. PubMed ID: 8679526 [TBL] [Abstract][Full Text] [Related]
40. Further studies on 2,4-diamino-5-(2',5'-disubstituted benzyl)pyrimidines as potent and selective inhibitors of dihydrofolate reductases from three major opportunistic pathogens of AIDS. Rosowsky A; Forsch RA; Queener SF J Med Chem; 2003 Apr; 46(9):1726-36. PubMed ID: 12699390 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]